WHAT CAN WE LEARN ABOUT RESPIRATORY DISEASES FROM COVID-19?
DOI:
https://doi.org/10.5281/zenodo.7269355Keywords:
Pathogen, exotic, acute bronchitis, pneumonia, SARS, influenza, pharyngitis, sinusitis, otitis mediaAbstract
Health care and other societal systems, as well as the global economy, have been profoundly affected by the COVID-19 pandemic. In most humanitarian emergencies, poorer developing nations have been hardest hit, and disadvantaged groups, especially those living in poverty and marginalized, have been disproportionately affected. During the initial phase of the pandemic, national response strategies to COVID-19 were largely similar in scope, but the timeliness, scale, and assertiveness of the responses varied greatly.
References
Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. L
World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). MERS Monthly Summary, November 2019, http: //www.who.int/emergencies/mers-cov/en/. Retrieved on 15 May 2022.
Li X, Ma X. (2020). Acute respiratory failure in COVID-19: is it "typical" ARDS?.
Ciceri F, Beretta L, Scandroglio AM, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acuterespiratory distress syndrome working hypothesis. Crit Care Resusc 2020;22:95-7.
Wang L, Wang Y, Ye D, Liu Q (March 2020). "Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence". International Journal of Antimicrobial Agents.
Baig AM, Khaleeq A, Ali U, Syeda H (April 2020). "Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms". ACS Chemical Neuroscience.
